JnJ faulty hip implants case: CIC directs RTI disclosure of records Ruby Khatun Khatun10 Sept 2018 12:26 PM ISTNew Delhi: A Johnson and Johnson subsidiary caught in a controversy over faulty hip replacement systems has opposed RTI disclosure of crucial...
Max Bupa launches WeCare initiative to aid Kerala flood victims Ruby Khatun Khatun10 Sept 2018 10:15 AM ISTNew Delhi: Health insurance player, Max Bupa has announced various initiatives and measures to support its customers and partners in Kerala, to cope...
Opposing Online Pharmacies, 8.5 lakh chemists to call it a strike on September 28 Ruby Khatun Khatun9 Sept 2018 10:55 AM ISTNew Delhi: In order to protest against the government decision to permit e-pharmacies, AIOCD, a representative body of around 8.5 lakh chemists in the...
Fortis arm sells 15 lakh shares in RHT to Fortis Healthcare International Ltd Ruby Khatun Khatun9 Sept 2018 10:15 AM ISTNew Delhi: Fortis Healthcare said that its step-down subsidiary RHT Health Trust Manager has sold 15 lakh shares in RHT Health Trust to Fortis...
FDA approves Cassipa as maintenance treatment for opioid dependence Ruby Khatun Khatun9 Sept 2018 10:00 AM ISTThe U.S. Food and Drug Administration (FDA) approved Cassipa (buprenorphine and naloxone) sublingual film (applied under the tongue) for the...
AstraZeneca gets FDA breakthrough therapy label for asthma treatment Ruby Khatun Khatun9 Sept 2018 9:45 AM ISTAstraZeneca Plc and Amgen Inc said the U.S. Food and Drug Administration had granted a breakthrough therapy label for their drug to treat a type of...
Pfizer terminates Domagrozumab clinical studies for Duchenne muscular dystrophy Ruby Khatun Khatun9 Sept 2018 9:30 AM ISTNew York: Pfizer Inc. announced today that it is terminating two ongoing clinical studies evaluating domagrozumab (PF-06252616) for the treatment of...
Supreme Court restrains Ministry of Health from taking a call on 15 banned FDC drugs Ruby Khatun Khatun8 Sept 2018 6:13 PM ISTThe 15 FDCs include those of big brands like Abbott Healthcare's Phensydyl, Paras Pharmaceutical's D-Cold Tablet, Alkem's Sumo, Franco-Indian...
Sun Pharma gets 6 observations by USFDA for its Halol facility Ruby Khatun Khatun8 Sept 2018 11:01 AM ISTNew Delhi: Drug major Sun Pharmaceutical Industries said the US health regulator has issued Form 483 with six observations after an inspection of its...
Johnson and Johnson says to work on India compensation for recalled hip implants Ruby Khatun Khatun8 Sept 2018 10:30 AM ISTMUMBAI: Johnson and Johnson said it would work with the Indian government to compensate patients who suffered from artificial hip implants the U.S....
Irdai ask insurers to provide 60-days grace period for health insurance premium Ruby Khatun Khatun8 Sept 2018 10:15 AM ISTNew Delhi: The insurance regulator Irdai Wednesday asked insurers to provide 60-days grace period for payment of health insurance premium in...
Renaming drug regulator CDSCO: Health ministry invites suggestions Ruby Khatun Khatun7 Sept 2018 1:28 PM ISTThe Drugs Technical Advisory Board (DTAB) in its 75th meeting held on January 3, 2017, had recommended renaming CDSCO as Indian Drugs Administration,...
